Exploring Clinical Advantageous Diseases and Core Acupoint Combinations of Jin's Three-Needle Therapy Based on Data Mining Techniques
10.13359/j.cnki.gzxbtcm.2025.10.019
- VernacularTitle:基于数据挖掘技术探讨靳三针疗法的临床优势病种及核心应用穴组
- Author:
Shumin LIN
1
;
Xiaorong TANG
;
Fanglin WANG
;
Lixing ZHUANG
Author Information
1. 广州中医药大学第一临床医学院,广东 广州 510006
- Keywords:
Jin's Three-Needle Therapy;
advantageous diseases;
core acupoint combinations;
data mining;
post-stroke hemiplegia;
autism spectrum disorder
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2025;42(10):2487-2495
- CountryChina
- Language:Chinese
-
Abstract:
Objective To systematically analyze the clinical advantageous diseases and core acupoint combinations of Jin's Three-Needle Therapy,providing data support for its broader clinical application.Methods The relevant literature from the China National Knowledge Infrastructure(CNKI),Wanfang Academic Journal Full-text Database,VIP Chinese Sci-Tech Journal Database,and China Biology Medicine(CBM)database were retrieved,covering all publications since the establishment of Jin's Three-Needle Therapy.A database of acupoint combinations was constructed,and statistical analyses were performed using SPSS Modeler,Cytoscape,Review Manager,Stata,and R software to evaluate literature quality,sensitivity,disease spectrum,therapeutic efficacy,high-frequency acupoint combinations,association rules,and combined therapies.Results A total of 228 eligible studies were included.The results indicate that Jin's Three-Needle Therapy has been applied to 11 disease categories and 63 specific conditions,with post-stroke hemiplegia and autism spectrum disorder identified as its primary advantageous diseases.The Temporal Three-Needle and Four-Spirit Needle emerged as the core acupoint combinations.The overall clinical efficacy rate reached 91.1%,and the therapy was frequently combined with rehabilitation training.Conclusion The unique three-needle prescription pattern of Jin's Three-Needle Therapy demonstrates significant clinical advantages.However,potential publication bias may exist,and further exploration is needed to elucidate its mechanisms and optimize clinical efficacy.